bioMérieux S.A. (BMXMF)
USD 103.09
(0.0%)
USD 103.09
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 3.67 Billion | 3.58 Billion | 3.37 Billion | 3.11 Billion | 2.67 Billion | 2.42 Billion |
| Cost of Revenue | 1.78 Billion | 1.58 Billion | 1.41 Billion | 1.36 Billion | 1.2 Billion | 1.11 Billion |
| Gross Profit | 1.88 Billion | 2 Billion | 1.96 Billion | 1.75 Billion | 1.46 Billion | 1.3 Billion |
| Operating Expenses | 1.44 Billion | 1.34 Billion | 1.16 Billion | 1.15 Billion | 1.07 Billion | 941.2 Million |
| Selling, General and Administrative Expenses | 1.02 Billion | 954.7 Million | 818.3 Million | 789.3 Million | 749.8 Million | 645.5 Million |
| Research and Development Expenses | 540.3 Million | 446.6 Million | 389 Million | 398.8 Million | 374.3 Million | 326.9 Million |
| Other Expenses | 57.5 Million | - | - | 50.5 Million | 40.7 Million | 34.9 Million |
| Cost and Expenses | 3.23 Billion | 2.92 Billion | 2.57 Billion | 2.52 Billion | 2.28 Billion | 2.06 Billion |
| Operating Income | 439 Million | 587.2 Million | 784.3 Million | 595.1 Million | 370.7 Million | 343.6 Million |
| Interest Expense | 4.4 Million | 4.1 Million | 9.1 Million | 24.9 Million | 22.1 Million | 16.9 Million |
| Income Tax Expense | 114.5 Million | 140.1 Million | 175.6 Million | 121.5 Million | 77.8 Million | 65.2 Million |
| Earnings before Tax | 437.5 Million | 580.5 Million | 774.3 Million | 525.4 Million | 347.3 Million | 320.9 Million |
| Net Income | 357.6 Million | 452.4 Million | 601.1 Million | 404.4 Million | 272.8 Million | 256.5 Million |
| Earnings Per Share Basic | 3.01 | 3.84 | 5.08 | 3.42 | 2.31 | 2.18 |
| Earnings Per Share Diluted | 3.01 | 3.82 | 5.06 | 3.41 | 2.30 | 2.17 |
| Weighted Average Shares Outstanding | 118.8 Million | 117.94 Million | 118.26 Million | 118.14 Million | 118.3 Million | 117.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 118.8 Million | 118.44 Million | 118.89 Million | 118.65 Million | 118.7 Million | 118.41 Million |
| Gross Margin | 0.51 | 0.56 | 0.58 | 0.56 | 0.55 | 0.54 |
| EBIT Margin | 0.19 | 0.26 | 0.31 | 0.26 | 0.22 | 0.22 |
| Profit Margin | 0.10 | 0.13 | 0.18 | 0.13 | 0.10 | 0.11 |
| EBITDA | 700.8 Million | 832.6 Million | 1 Billion | 808.9 Million | 558.9 Million | 517.3 Million |
| Earnings Before Tax Margin | 0.12 | 0.16 | 0.23 | 0.19 | 0.14 | 0.14 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 1.9 Billion | 3.67 Billion | 1.9 Billion | 1.77 Billion | 3.58 Billion | 1.93 Billion |
| Cost of Revenue | 839.1 Million | 1.78 Billion | 933.5 Million | 854.5 Million | 1.58 Billion | 912.1 Million |
| Gross Profit | 1.06 Billion | 1.88 Billion | 971.1 Million | 915.6 Million | 2 Billion | 1.01 Billion |
| Operating Expenses | 774.5 Million | 1.44 Billion | 752 Million | 728.6 Million | 1.34 Billion | 753.7 Million |
| Selling, General and Administrative Expenses | 536.2 Million | - | 518.4 Million | 502.1 Million | - | 514.4 Million |
| Research and Development Expenses | 260.6 Million | - | 233.6 Million | 226.5 Million | - | 239.3 Million |
| Other Expenses | -22.3 Million | 33 Million | - | - | - | - |
| Cost and Expenses | 1.61 Billion | 3.23 Billion | 1.68 Billion | 1.58 Billion | 2.92 Billion | 1.66 Billion |
| Operating Income | 288.3 Million | 439.1 Million | 219.1 Million | 187 Million | 587.2 Million | 265.3 Million |
| Interest Expense | 3.2 Million | 4.4 Million | - | 2.2 Million | 4.1 Million | - |
| Income Tax Expense | 68.5 Million | 114.5 Million | 34.3 Million | 55.6 Million | 140.1 Million | 57.9 Million |
| Earnings before Tax | 283.4 Million | 437.3 Million | 218.4 Million | 194.3 Million | 580.5 Million | 272.2 Million |
| Net Income | 215.3 Million | 357.6 Million | 196 Million | 161.6 Million | 452.4 Million | 224.3 Million |
| Earnings Per Share Basic | 1.82 | - | 1.66 | 1.37 | - | 1.90 |
| Earnings Per Share Diluted | 1.82 | - | 1.65 | 1.36 | - | 1.89 |
| Weighted Average Shares Outstanding | 118.29 Million | 118.15 Million | 118.15 Million | 117.95 Million | 117.94 Million | 117.94 Million |
| Weighted Average Shares Outstanding (Diluted) | 118.59 Million | 118.8 Million | 118.95 Million | 118.61 Million | 118.44 Million | 118.5 Million |
| Gross Margin | 0.56 | 0.51 | 0.51 | 0.52 | 0.56 | 0.53 |
| EBIT Margin | 0.21 | - | 0.22 | 0.21 | - | 0.22 |
| Profit Margin | 0.11 | 0.10 | 0.10 | 0.09 | 0.13 | 0.12 |
| EBITDA | 399.8 Million | - | 421.5 Million | 373.6 Million | - | 426.6 Million |
| Earnings Before Tax Margin | 0.15 | 0.12 | 0.12 | 0.11 | 0.16 | 0.14 |
7269
CHV
078000
6307
AIL
21STCENMGM